A Cost-effectiveness Analysis of Antipsychotics for Treatment of Schizophrenia in Uganda

被引：0
|
作者：
Solomon J. Lubinga
Byamah B. Mutamba
Angelo Nganizi
Joseph B. Babigumira
机构：
[1] University of Washington,Pharmaceutical Outcomes Research and Policy Program, Department of Pharmacy
[2] University of Washington,Global Medicines Program, Department of Global Health
[3] Butabika National Referral Hospital for Mental,undefined
[4] Neurological and Substance Abuse Disorders,undefined
[5] Kadic Hospital,undefined
来源：
Applied Health Economics and Health Policy | 2015年 / 13卷
关键词：
Schizophrenia; Haloperidol; Risperidone; Olanzapine; Quetiapine;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：493 / 506
页数：13
相关论文
共 50 条
  • [21] Cost-effectiveness in the treatment of schizophrenia
    Knapp, MRJ
    EUROPEAN PSYCHIATRY, 1996, 11 (03) : 137 - 143
  • [22] COST-EFFECTIVENESS ANALYSIS OF LURASIDONE AND OLANZAPINE IN THE TREATMENT OF SCHIZOPHRENIA
    Priyadarshini, M.
    Hay, J. W.
    VALUE IN HEALTH, 2016, 19 (03) : A188 - A189
  • [23] Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US
    O'Day, Ken
    Rajagopalan, Krithika
    Meyer, Kellie
    Pikalov, Andrei
    Loebel, Antony
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2013, 5 : 459 - 470
  • [24] COST-EFFECTIVENESS IN THE TREATMENT OF PATIENTS WITH SCHIZOPHRENIA
    GOLDBERG, D
    ACTA PSYCHIATRICA SCANDINAVICA, 1994, 89 : 89 - 92
  • [25] Schizophrenia costs and treatment cost-effectiveness
    Knapp, M
    ACTA PSYCHIATRICA SCANDINAVICA, 2000, 102 : 15 - 18
  • [26] Cost-effectiveness of atypical antipsychotics in the treatment of acute mania
    Meletiche, DM
    Meyer, K
    Franklin, M
    Poston, S
    Grogg, A
    VALUE IN HEALTH, 2006, 9 (03) : A66 - A67
  • [27] Rifampicin for Continuation Phase Tuberculosis Treatment in Uganda: A Cost-Effectiveness Analysis
    Manabe, Yukari C.
    Hermans, Sabine M.
    Lamorde, Mohammed
    Castelnuovo, Barbara
    Mullins, C. Daniel
    Kuznik, Andreas
    PLOS ONE, 2012, 7 (06):
  • [28] COST-EFFECTIVENESS ANALYSIS OF DIFFERENT TREATMENT STRATEGIES FOR SCHIZOPHRENIA IN CHINA
    Du, X. M.
    Huang, Y.
    VALUE IN HEALTH, 2023, 26 (06) : S126 - S126
  • [29] A cost-effectiveness analysis model for treatment of chronic schizophrenia in Mexico
    Mould, J
    Contreras-Hernandez, I
    Verduzco, W
    Garduño-Espinosa, J
    VALUE IN HEALTH, 2006, 9 (03) : A67 - A67
  • [30] A cost-effectiveness clinical decision analysis model for treatment of schizophrenia
    Palmer, CS
    Brunner, E
    Ruíz-Flores, LG
    Paez-Agraz, F
    Revicki, DA
    ARCHIVES OF MEDICAL RESEARCH, 2002, 33 (06) : 572 - 580
12345